Orthox Closes $12.5m Series A Financing for Clinical Trials of Knee Cartilage Repair FibroFix™ Product Platform

Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries, announces the completion of a further $4.

Related Keywords

Bristol ,City Of ,United Kingdom ,Oxfordshire ,Cambridge ,Cambridgeshire ,Budapest ,Hungary ,Hungarian ,Nick Skaer ,Oneil Cameron ,Orthoxnick Skaer ,Orthox Fibrofix ,International Orthopaedics ,Oxford Technology Innovations ,Additio Investment Group Raj Airey ,Biomedical Catalyst Fund Award ,United Kingdom Innovation Agency ,Imperial College ,Scius Communications ,Late Stage Product Development ,Wellcome ,Additio Investment Group ,Prnewswire Orthox ,Oxford University ,Agency For Healthcare Research ,Oxford Investment Consultants ,Healthcare Life Sciences ,Southmead Hospital Bristol ,Oxford Technology ,Additio Investment ,Investment Director ,Raj Airey ,Healthcare Research ,Translation Awards ,Late Stage Product Development Awards ,Innovation Agency ,Parkwalk Opportunities ,Knowledge Intensive ,Life Sciences ,Venture Partners ,Orthox ,Series , ,Ealth Press Release ,